New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq ・ Market Cap: Small
CEO Purchases
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 2 / 8 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 2 / 4 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 559,805 / 796,053 279,903 / 99,507 |
| VALUE PURCHASED/SOLD Transaction Average | $7,525,365 / $10,304,661 $3,762,683 / $1,288,083 |
| PURCHASE RANGE | $25,372.5 - $7,499,992.5 |
| SALE RANGE | $1,500 - $7,177,500 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
1 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
0.76%
DIRECTORS
0%
OFFICERS
99.24%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.497 0.2 |
VALUE GINI INDEX Sector Average | 0.492 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
86.41%
DIRECTORS
13.59%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.53 0.295 |
VALUE GINI INDEX Sector Average | 0.527 0.288 |
Mineralys Therapeutics, Inc. 1Y Trade Transactions